As longevity and regenerative medicine continue to evolve, a growing number of therapies are being explored to support healthy aging at the cellular level. These approaches differ significantly in mechanism, scope, and clinical intent—from metabolic regulation and epigenetic modulation to tissue repair and growth pathway control.
This article provides a clear comparison of five commonly discussed longevity-focused therapies:
-
OS-01 (ATX-304) – 100 mg capsules
-
AMPK O-304 capsules
-
NAD⁺ injections
-
GHK-Cu injections
-
Rapamycin
Understanding how these therapies differ helps clarify where each fits within a comprehensive longevity or wellness framework.
OS-01 (ATX-304) – 100 mg Capsules
OS-01 (ATX-304) is a small-molecule compound studied for its role in epigenetic aging and metabolic regulation. Unlike hormone replacement or symptom-focused therapies, OS-01 is designed to act upstream, influencing how cells express genes associated with aging, inflammation, and cellular senescence.
By targeting pathways involved in biological aging, OS-01 is positioned as a longevity-focused compound rather than a short-term performance or repair intervention. Oral capsule formulations (such as 100 mg capsules) are typically discussed in research and investigational contexts.
Primary focus:
-
Epigenetic regulation
-
Cellular aging biology
-
Longevity signaling
AMPK O-304 Capsules
AMPK O-304 is designed to activate AMP-activated protein kinase (AMPK), a master regulator of cellular energy balance. AMPK plays a central role in how cells respond to energy availability, stress, and aging.
Activation of AMPK shifts cells away from excessive growth and toward maintenance, repair, and metabolic efficiency—a pathway often associated with exercise and caloric restriction signaling.
Primary focus:
-
Cellular energy sensing
-
Metabolic optimization
-
Autophagy and stress resilience
NAD⁺ Injections
NAD⁺ (nicotinamide adenine dinucleotide) is an essential coenzyme involved in mitochondrial energy production and DNA repair. NAD⁺ levels naturally decline with age, stress, and chronic illness.
NAD⁺ injections are commonly discussed in clinical wellness settings for energy restoration and cellular repair support, rather than direct epigenetic or metabolic reprogramming.
Primary focus:
-
Mitochondrial energy production
-
DNA repair mechanisms
-
Cellular stress response
GHK-Cu (Copper Peptide) Injections
GHK-Cu is a bioactive copper peptide best known for its role in tissue repair, collagen synthesis, and regenerative signaling. Unlike systemic longevity compounds, GHK-Cu primarily acts downstream, signaling cells to repair and remodel tissue.
It is frequently discussed in the context of skin health, wound healing, and regenerative medicine, rather than metabolic or aging pathway control.
Primary focus:
-
Tissue regeneration
-
Collagen and extracellular matrix support
-
Localized repair signaling
Rapamycin
Rapamycin is a prescription medication that inhibits mTOR (mechanistic target of rapamycin), a key growth and nutrient-sensing pathway. In aging research, mTOR inhibition is associated with shifting cells from growth toward maintenance and repair.
Rapamycin has extensive animal longevity data and is actively studied in human clinical research. Its use requires careful medical oversight due to potential immune and metabolic effects.
Primary focus:
-
Growth pathway modulation
-
Cellular maintenance signaling
-
Longevity research
Longevity Therapy Comparison Chart
| Therapy | Primary Target | Main Biological Role | Upstream vs Downstream | Delivery Form | Primary Focus |
|---|---|---|---|---|---|
| OS-01 (ATX-304) | Epigenetic aging pathways | Gene expression & cellular aging | Upstream | Oral capsule (100 mg) | Longevity biology |
| AMPK O-304 | AMPK | Energy sensing & metabolism | Upstream | Oral capsule | Metabolic optimization |
| NAD⁺ | Redox & repair enzymes | Energy production & DNA repair | Mid-upstream | Injection | Cellular energy |
| GHK-Cu | Repair signaling pathways | Tissue regeneration & collagen | Downstream | Injection | Regenerative support |
| Rapamycin | mTOR | Growth & nutrient signaling | Upstream | Oral (prescription) | Longevity research |
How These Therapies Differ Conceptually
Rather than competing therapies, these approaches act on different layers of cellular health:
-
AMPK O-304 improves how cells manage energy
-
NAD⁺ supports the fuel and repair systems within cells
-
OS-01 (ATX-304) influences how cells age at the genetic level
-
GHK-Cu enhances tissue repair and regeneration
-
Rapamycin modulates growth signaling associated with aging
Each addresses a distinct aspect of aging biology.
Final Thoughts
Longevity-focused care is shifting toward upstream, systems-based approaches that aim to optimize how cells function over time—not just how symptoms are managed. Understanding the differences between metabolic regulators, epigenetic compounds, regenerative peptides, and growth pathway modulators is essential for informed clinical discussions.
As with all advanced therapies, medical evaluation, regulatory considerations, and individualized decision-making are critical.
